Novo Nordisk A/SNVO

Is NVO cheap right now? Every multiple below is scored against its own 10-year range, not a sector average.

$43.45+0.38 (+0.88%)24:00 UTC
NYSEHealthcare

Company snapshot

Market Cap
$193B
Large-cap
+70%
2016 — today
10-Year Price
+95%
2016 — today
52-Week Range
$35.29$63.98
Current $43.45· 28%

Novo Nordisk (est. 1923, Bagsvaerd, Denmark) researches, manufactures, and distributes pharmaceuticals across Europe, the Middle East, Africa, Asia, and North America. Operations span two units: Diabetes and Obesity Care—covering diabetes, obesity, and cardiovascular therapies—and Rare Disease, focusing on blood disorders, endocrine conditions, and hormone replacement. Beyond drugs, it produces insulin/growth hormone pens and digital diabetes management tools. It maintains strategic partnerships, including collaborations with UNICEF and Valo Health.

Similar companies

Healthcare companies of comparable size to NVO
CompanyP/EDiv yield
GILDGilead Sciences, Inc.-54.82.2%
ABTAbbott Laboratories33.12.4%
AMGNAmgen Inc.23.72.6%
TMOThermo Fisher Scientific Inc.33.00.3%
PFEPfizer Inc.36.66.2%
AZNAstraZeneca PLC24.62.0%
DHRDanaher Corporation36.10.7%
NVSNovartis AG21.03.4%

Healthcare companies of comparable size — each one shown against its own 10-year range, not a sector average. Browse all stocks we cover.

Valuation in context

P/E ratio
10.7
Near historic low
Near historic low — last 10 years
Sector median 25.2below sector
P/B ratio
5.6
Near historic low
Near historic low — last 10 years
Sector median 2.5above sector
EV / EBITDA
7.4
Near historic low
Near historic low — last 10 years
Sector median 15.4below sector
Dividend Yield
4.1%
Near historic high
Near historic highs — last 10 years
Sector median 1.7%above sector
PEG ratio
0.5
Near historic low
Near historic low — last 10 years
Sector median 1.5below sector
FCF Yield
3.9%
Above average
Above the 10-year average
Sector median -10.1%above sector
Free · No credit card needed

Get alerted when NVO is cheap

Set a free alert — we'll push you when P/E, yield, or other metrics cross a historical threshold.